An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Long term outcome of Pigmentary Maculopathy after Elmiron — Research Summary — detailed background and analysis.
Reference: World Health Organization (WHO)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Mayo Clinic — Diseases & Conditions
Authoritative source for clinical, regulatory, and public-health background reading.